Sanofi

Stocks

SAN

FR0000120578

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-07-21 am EDT			After hours 12:52:47 pm
76.75 ^EUR	-0.21%		76.76	+0.01%

12:11pm	Sanofi tightens its Executive Committee
Jul. 20	SANOFI : Gets a Neutral rating from JP Morgan	ZD

Transcript : Sanofi - Shareholder/Analyst Call

Published on 06/13/2026 at 12:36 am EDT - Modified on 06/15/2026 at 10:11 am EDT

S&P Capital IQ

Add MarketScreener to your sources

Presenter Speech
Frederic Oudea (Executives)

[Interpreted] Ladies and gentlemen, dear shareholders, good afternoon. I hereby declare open the Annual General Meeting of the Sanofi Company, a meeting

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Add MarketScreener to your sources

Latest news about Sanofi

12:11pm	Sanofi tightens its Executive Committee
Jul. 20	SANOFI : Gets a Neutral rating from JP Morgan	ZD
Jul. 20	European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading	MT
Jul. 20	Eli Lilly May Raise Stake in Scribe Therapeutics to 10.9% Through IPO	MT
Jul. 20	Eli Lilly May Raise Stake in Scribe Therapeutics to 10.9% Stake Through IPO	MT
Jul. 20	Scribe Therapeutics to Sell 7.15 Million Shares at $13-$15 Each in IPO	DJ
Jul. 17	Sanofi strengthens its research alliance with Aqemia
Jul. 17	Aqemia and Sanofi Expand Research Collaboration	CI
Jul. 16	Merck gets US FDA nod for first-in-its-class oral cholesterol drug	RE
Jul. 14	European Equities Traded in the US as American Depositary Receipts Rise Tuesday	MT
Jul. 14	Where would AI lead Pharma in the long run?
Jul. 14	AlphaValue/Baader Europe Downgrades Sanofi to Add, Trims PT	MT
Jul. 13	SANOFI : UBS reiterates its Neutral rating	ZD
Jul. 13	EXECUTIVE CHANGES: Rank Group confirms interim CEO Harris as permanent	AN
Jul. 10	Sanofi Receives Fda Approval for Subcutaneous Sarclisa Escena Administered Via On-Body Injector	CI